N. Mulder

发表

[18F]FHPG Positron Emission Tomography for Detection of Herpes Simplex Virus (HSV) in Experimental HSV Encephalitis

A. van Waarde, W. Vaalburg, J. Garssen, 2005, Journal of Virology.

Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

P. Borst, E. de Vries, M. Müller, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.

L. de Leij, P. Postmus, S. Poppema, 1988, Cancer research.

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.

N. Mulder, E. de Vries, N. Mulder, 1990, British Journal of Cancer.

Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug‐resistance protein 1

N. Mulder, E. de Vries, M. Müller, 1998, International journal of cancer.

The effect of amphotericin B lozenges on the presence and number of candida cells in the oropharynx of neutropenic leukemia patients

D. Sleijfer, N. Mulder, H. V. Saene, 2005, Infection.

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

L. de Leij, Wiley Interscience, N. Mulder, 2005, Journal of clinical apheresis.

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study.

H. Groen, E. de Vries, J. Hermans, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Low-dose regimen of interleukin-2 for metastatic renal carcinoma

N. Mulder, A. Martens, P. Willemse, 1990, The Lancet.

Chapter VII The addition of low-dose leucovorin to the combination of 5-fluorouracil-levamisole does not improve survival in the adjuvant treatment of Dukes’ C colon cancer

J. Hermans, N. Mulder, W. Bleeker, 2001 .

The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.

J. Hermans, R. Otter, N. Mulder, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma

D. Sleijfer, E. Vries, N. Mulder, 2005, Journal of Cancer Research and Clinical Oncology.

Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma

D. Sleijfer, E. Vries, N. Mulder, 2004, Journal of Cancer Research and Clinical Oncology.

Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.

E. D. de Vries, H. Rosing, J. Beijnen, 2002, Gynecologic oncology.

High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.

E. de Vries, D. Sleijfer, N. Mulder, 1985, European journal of cancer & clinical oncology.

Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.

H. Hollema, E. de Vries, N. Mulder, 1997, British Journal of Cancer.

A reduction in pulmonary capillary blood volume in patients with disseminated testicular carcinoma.

H. Sluiter, T. W. van der Mark, N. Mulder, 1985, European journal of cancer & clinical oncology.

Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin‐vinblastine‐bleomycin chemotherapy

D. Sleijfer, N. Mulder, J. Oosterhuis, 1988, Journal of surgical oncology.

The addition of low-dose leucovorin to the combination of 5-fluorouracillevamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer

J. Plukker, J. Hermans, R. Otter, 2000 .

Adjuvant treatment for cancer of the colon and rectum.

N. Mulder, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Immune Targeting of T-Lymphocytes

J. Buter, N. Mulder, D. Sleijfer, 1993 .

Bispecific Monoclonal Antibody (Biab)-Retargeted Cellular Therapy for Local Treatment of Cancer Patients

P. Willemse, E. Vries, M. Elias, 1990 .

Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study.

E. de Vries, D. Sleijfer, N. Mulder, 1984, European journal of cancer & clinical oncology.

FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences.

A. Paans, H. Hoekstra, R. V. van Ginkel, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

University of Groningen DNA topoisomerase II alpha and -beta expression in human ovarian cancer

H. Hollema, S. Withoff, E. Vries, 2018 .

DNA topoisomerase IIα and -β expression in human ovarian cancer

H. Hollema, S. Withoff, E. Vries, 1999, British Journal of Cancer.

Role of the glutathione S-conjugate pump in cisplatin resistance.

E. de Vries, M. Müller, P. Jansen, 1995, Journal of the National Cancer Institute.

Analysis of extramedullary erythropoiesis in the spleen by a semiquantitative method using indium-111.

D. Piers, N. Mulder, R. Rojer, 2009, Acta medica Scandinavica.

A study of human small‐cell lung carcinoma (hsclc) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (cddp) resistance

L. de Leij, N. Mulder, E. de Vries, 1990, International journal of cancer.

Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer.

L. de Leij, P. Schrier, E. Hooijberg, 2000, Anticancer research.

The effect of continuous enteral tube feeding on various nutritional parameters in patients with disseminated malignant melanoma during intensive chemotherapy.

D. Sleijfer, N. Mulder, H. Schraffordt koops, 1983, Clinical nutrition.

The impact of haematopoietic growth factors on supportive care in clinical oncology : With special attention to potential tumour cell contamination in the stem cell harvest

E. Vellenga, P. Willemse, E. Vries, 1998 .

A phase I and pharmacokinetic study of intraperitoneal topotecan

H. Rosing, J. Beijnen, P. Willemse, 2001, British Journal of Cancer.

High‐dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors

E. de Vries, W. T. van der Graaf, N. Mulder, 1995, Stem cells.

Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update.

L. de Leij, J. Buter, D. Sleijfer, 1996, Cancer biotherapy & radiopharmaceuticals.

Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects.

L. de Leij, J. Buter, N. Mulder, 1995, Journal of Hematotherapy.

Infection after subcutaneous interleukin-2

J. Buter, D. Sleijfer, E. Vries, 1992, The Lancet.

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

H. Keizer, E. Vellenga, E. de Vries, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes

H. Timmer-Bosscha, G. Hospers, N. Mulder, 2000, British Journal of Cancer.

Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy

H. Hollema, E. Vries, N. Mulder, 2007 .

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

E. de Vries, R. Scheper, G. Hospers, 1988, Cancer research.

Acute and cumulative effects of carboplatin on renal function.

E. Smit, P. Postmus, D. Sleijfer, 1989, British Journal of Cancer.

The protective potential of the combination of verapamil and cimetidine on cisplatin‐induced nephrotoxicity in man

N. Mulder, M. Verweij, H. Koops, 1987, Cancer.

Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.

A. Donker, P. D. de Jong, W. Sluiter, 1983, Oncology.

Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: An update

J. Bouma, E. Vries, D. Sleijfer, 1987 .

Tube feeding of cancer patients treated with chemotherapy

E. Vries, N. Mulder, W. M. Kreumer, 1985, Medical oncology and tumor pharmacotherapy.

Topoisomerases, New Targets in Cancer Chemotherapy

J. Zijlstra, E. Vries, N. Mulder, 1990, Medical oncology and tumor pharmacotherapy.

Human Telomere Length in Breast Cancer Patients before and after Chemotherapy with or without Stem Cell Transplantation

G. Wisman, A. V. D. van der Zee, E. Vries, 2000 .

'Classic' and 'acute' myelofibrosis. A retrospective study.

N. Mulder, R. Rojer, H. Nieweg, 1978, Acta haematologica.

Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis.

E. Vellenga, E. de Vries, P. Nieboer, 2004, European journal of cancer.

Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours

P. Willemse, P. Nieboer, E. Vries, 2001, Bone Marrow Transplantation.

Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6).

A. Donker, N. Mulder, D. Sleijfer, 1985, European journal of cancer & clinical oncology.

Gene therapy: from fiction to factual tool?

N. Mulder, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.

E. de Vries, M. V. van Luyn, N. Mulder, 2001, Biochemical pharmacology.

Antagonism of HSV-tk Transfection and Ganciclovir Treatment on Chemotherapeutic Drug Sensitivity

A. V. D. Van Der Zee, W. Vaalburg, N. Mulder, 2005, Journal of chemotherapy.

Ablative Chemotherapy in Solid Tumour Oncology, Technology in Search of an Application?

N. Mulder, P. O. Mulder, 1997 .

Predictive factors for bleomycin-induced pneumonitis.

H. Sluiter, T. W. van der Mark, N. Mulder, 1984, The American review of respiratory disease.

INFLUENCE OF DOCOSAHEXANOIC ACID (22-6) INVITRO ON INTRACELLULAR ADRIAMYCIN CONCENTRATION IN LYMPHOCYTES AND HUMAN ADRIAMYCIN SENSITIVE AND ADRIAMYCIN-RESISTANT SMALL-CELL LUNG-CANCER CELL-LINES, AND ON CYTOTOXICITY IN THE TUMOR-CELL LINES

J. Zijlstra, H. Timmer-Bosscha, N. Mulder, 1987 .

Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells

P. Limburg, P. Willemse, E. Vries, 1993, Cancer Immunology, Immunotherapy.

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

L. de Leij, T. The, N. Mulder, 1993, British Journal of Cancer.

Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.

L. de Leij, J. Buter, D. Sleijfer, 1993, European journal of cancer.

Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma.

L. de Leij, T. The, N. Mulder, 1992, British Journal of Cancer.

Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients.

L. de Leij, P. D. de Jong, J. Buter, 1992, European journal of cancer.

Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma.

D. Sleijfer, N. Mulder, H. Schraffordt koops, 1983, Oncology.

The influence of verapamil on renal function in patients treated with cisplatin.

A. Donker, N. Mulder, H. Schraffordt koops, 1985, Clinical nephrology.

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

D. Sleijfer, N. Mulder, D. van der Waaij, 1981, Antimicrobial Agents and Chemotherapy.

INTENSIVE INDUCTION CHEMOTHERAPY AND INTENSIFICATION WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH STAGE-IIIB AND STAGE-IV BREAST-CANCER

P. Willemse, N. Mulder, D. Sleijfer, 1988 .

Approaches to lung cancer treatment using the CD3E×GP-2-directed Bispecific Monoclonal Antibody BIS-1

H. Groen, L. de Leij, E. de Vries, 1997, Cancer Immunology, Immunotherapy.

Prolonged continuous infusion of low-dose rIL-2.

L. de Leij, J. Buter, T. The, 1994, British Journal of Cancer.

Dendritic Cells Present an Intracellular Viral Antigen Derived from Apoptotic Cells and Induce a T‐Cell Response

L. de Leij, M. Harmsen, T. The, 2002, Scandinavian journal of immunology.

TRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATION

N. Mulder, J. Elema, P. Postmus, 1989, The Lancet.

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

H. Groen, P. Willemse, D. Sleijfer, 1999, British journal of cancer.

Monitoring HSVtk suicide gene therapy: the role of [18F]FHPG membrane transport

A. van Waarde, W. Vaalburg, E. D. de Vries, 2004, British Journal of Cancer.

Mechanisms of cellular resistance to cisplatin

E. Vries, G. Hospers, N. Mulder, 1988, Medical oncology and tumor pharmacotherapy.

Comparison between a Human Small Cell Lung Carcinoma Cell Line (GLC4) and an Adriamycin (GLC4-ADR) and a CDDP (GLC4-CDDP) Resistant Subline. A Preliminary Report

J. Zijlstra, E. Vries, G. Hospers, 1988 .

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

D. Sleijfer, N. Mulder, D. van der Waaij, 1980, European journal of cancer.

The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications.

E. Vellenga, E. de Vries, N. Mulder, 2004, European journal of cancer.

Bleomycin and pulmonary toxicity.

T. W. van der Mark, N. Mulder, D. Sleijfer, 1985, The Netherlands journal of medicine.

H. Elzinga, N. Mulder, F. A. Muskiet, 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

L. de Leij, J. Buter, T. The, 1994, British journal of cancer.

A PHASE-I STUDY OF IOBAPLATIN (D-19466) ADMINISTERED BY 72H CONTINUOUS INFUSION

J. Gietema, N. Mulder, H. Guchelaar, 1993 .

Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography.

W Vaalburg, A Calogero, A. van Waarde, 2000, Cancer research.

, A . ( HSV ) in Experimental HSV Encephalitis for Detection of Herpes Simplex Virus F ] FHPG Positron Emission Tomography 18

A. van Waarde, W. Vaalburg, J. Garssen, 2005 .

Clinical Application of Cryopreserved Stem Cells and Platelets in a Bone Marrow Transplant Program

P. Willemse, E. Vries, N. Mulder, 1990 .

Autologous Bone Marrow Transplantation in Solid Malignancies

E. Vries, N. Mulder, P. Willemse, 1987 .

Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria

E. Vellenga, T. The, C. Kallenberg, 1983, Blut.

Relevance of high-dose chemotherapy in solid tumours.

N. Mulder, E. de Vries, P. Nieboer, 2005, Cancer treatment reviews.

Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review

N. Mulder, G. Hospers, R. Tio, 2003, International journal of cardiovascular interventions.

Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantation

F. Arnaud, N. Mulder, C. S. Smit Sibinga, 1983, Blut.

Graft versus host disease after transfusions of non-irradiated blood cells in patients having received autologous bone marrow. A report of 4 cases following ablative chemotherapy for solid tumors.

N. Mulder, J. Elema, P. Postmus, 1988, European journal of cancer & clinical oncology.

PHARMACOKINETICS OF VINCRISTINE

N. Mulder, P. Postmus, E. Devries, 1988 .

Short-term continuous infusion of mitozantrone for advanced breast cancer

D. Sleijfer, E. Vries, N. Mulder, 1990, The Lancet.

The value of prognostic indices in aplastic anaemia

D. Sleijfer, N. Mulder, H. Nieweg, 1981, Blut.

Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism

E. Vries, A. Wymenga, N. Mulder, 1999, Bone Marrow Transplantation.

The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis

E. Vellenga, N. Mulder, A. V. Zanten, 2004, European Journal of Nuclear Medicine.

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

R. Pieters, K. Sikora, W. Siegert, 1991, Journal of Cancer Research and Clinical Oncology.

Natural course of bleomycin-induced pneumonitis. A follow-up study.

H. Sluiter, T. W. van der Mark, N. Mulder, 1987, The American review of respiratory disease.

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.

S. Withoff, E. de Vries, A. Knol, 1996, British Journal of Cancer.

Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma

P. Jong, W. Sluiter, N. Mulder, 2004, Cancer Chemotherapy and Pharmacology.

Recombinant T-cell receptors: an immunologic link to cancer therapy.

L. de Leij, G. Hospers, N. Mulder, 2000, Journal of immunotherapy.

Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.

E. de Vries, D. Sleijfer, N. Mulder, 1988, European journal of cancer & clinical oncology.

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.

L. de Leij, J. Buter, T. The, 1995, British Journal of Cancer.

Phase I study of 21 days continuous infusion with vindesine.

E. de Vries, N. Mulder, E. Smit, 1989, British Journal of Cancer.

High-dose etoposide for refractory malignancies: a phase I study.

E. de Vries, N. Mulder, P. Postmus, 1984, Cancer treatment reports.

ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPY

E. Vellenga, N. Mulder, H. Nieweg, 1980, The Lancet.

No narcosis for bone marrow harvest in autologous bone marrow transplantation

E. Vries, N. Mulder, P. Postmus, 1984, Blut.

ADRIAMYCIN (ADR) RESISTANCE IN A HUMAN SMALL-CELL LUNG-CANCER (SCLC) CELL-LINE

J. Zijlstra, N. Mulder, E. Devries, 1986 .

Acquired pancytopenia in relatives of patients with aplastic anaemia.

G. Anders, D. Sleijfer, N. Mulder, 2009, Acta medica Scandinavica.

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5‐fluorouracil

D. Sleijfer, N. Mulder, R. Verschueren, 1991, The British journal of surgery.

NIEHS, UNC and Duke Instate Training Program

J. Buter, T. The, N. Mulder, 1994, British Journal of Cancer.

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

A. Smit, P. Quax, G. Hospers, 2006, Human Gene Therapy.

Normal levels of antithrombin III in acute leukemia complicated by coagulopathy.

E. Vellenga, N. Mulder, 1980, Acta haematologica.

A study of the cellular and humoral immune response in patients with myelofibrosis.

E. Vellenga, T. The, N. Mulder, 2008, Clinical and laboratory haematology.

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

S. Rodenhuis, H. Boezen, M. Nooij, 2008, Bone Marrow Transplantation.

Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables

H. Crijns, M. P. van den Berg, E. D. de Vries, 1999, Heart.

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

D J van Veldhuisen, H S Koops, M. P. van den Berg, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer.

H. D. de Bruijn, E. de Vries, N. Mulder, 1997, Gynecologic oncology.

Modulation of death receptor pathways in oncology.

E. D. de Vries, D. Spierings, S. de Jong, 2003, Drugs of today.

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer

S. Rodenhuis, M. Bontenbal, E. Vries, 2005, Breast Cancer Research and Treatment.

Vascular problems in paroxysmal nocturnal haemoglobinuria

E. Vellenga, C. Gips, N. Mulder, 1982, Blut.

Response to pyridoxine hydrochloride in refractory anemia due to myelofibrosis.

N. Mulder, R. Rojer, H. Nieweg, 1978, The American journal of medicine.

ENDOTOXIN IN PAROXYSMAL NOCTURNAL HAEMOGLOBULINURIA (PNH)

E. Vellenga, N. Mulder, H. Vries-Hospers, 1982, British journal of haematology.